Vascular Vision Pharmaceuticals Co.

Top Publications

Top Publications Authored or Co-Authored in "Vascular Vision Pharmaceuticals Co."

• The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor

  Anticancer Research, Volume 29, No. 11, Year 2009, Citations 10
• Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin

  Anticancer Research, Volume 31, No. 2, Year 2011, Citations 8
• Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway

  Journal of Translational Medicine, Volume 16, No. 1, Article 243, Year 2018, Citations 8
• Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia

  Haematologica, Volume 107, No. 2, Year 2022, Citations 5
• Angiogenesis modulation by nicotine and nicotinic ligands

  Journal of Pediatric Biochemistry, Volume 1, No. 2, Year 2010, Citations 2